Maruyama, Kazuo
Teikyo University,
Japan
2025 Rank: 41981
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 346 out of 157499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 41981 | 39938 |
| Total Cites | 10532 | 12487 |
| H-index | 47 | 55 |
| Hm-index | 18 | 20 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 715 | 722 |
| Number of Single+First Authored Papers | 48 | 48 |
| Total Cites to Single+First Authored Papers | 2279 | 2503 |
| Number of Single+First+Last Authored Papers | 112 | 112 |
| Total Cites to Single+First+Last Authored Papers | 3674 | 4376 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8126 | 8682 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.44 |
| Self-Citation Percentage |
15.66%
|
|
Maruyama, Kazuo
Teikyo University,
Japan
2024 Rank: 37255
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 313 out of 148458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 37255 | 36373 |
| Total Cites | 10611 | 12652 |
| H-index | 48 | 54 |
| Hm-index | 19 | 21 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 679 | 686 |
| Number of Single+First Authored Papers | 47 | 47 |
| Total Cites to Single+First Authored Papers | 2201 | 2425 |
| Number of Single+First+Last Authored Papers | 119 | 119 |
| Total Cites to Single+First+Last Authored Papers | 3744 | 4440 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8283 | 8927 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.42 |
| Self-Citation Percentage |
16.13%
|
|
Maruyama, Kazuo
Teikyo University,
Japan
2023 Rank: 36398
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 313 out of 140593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 36398 | 34523 |
| Total Cites | 10266 | 12243 |
| H-index | 47 | 54 |
| Hm-index | 18 | 20 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 640 | 647 |
| Number of Single+First Authored Papers | 47 | 47 |
| Total Cites to Single+First Authored Papers | 2128 | 2352 |
| Number of Single+First+Last Authored Papers | 119 | 119 |
| Total Cites to Single+First+Last Authored Papers | 3591 | 4262 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8022 | 8665 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.41 |
| Self-Citation Percentage |
16.15%
|
|
Maruyama, Kazuo
Teikyo University,
Japan
2022 Rank: 35625
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 307 out of 134745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 35625 | 33959 |
| Total Cites | 9708 | 11602 |
| H-index | 46 | 52 |
| Hm-index | 17 | 19 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 595 | 602 |
| Number of Single+First Authored Papers | 48 | 48 |
| Total Cites to Single+First Authored Papers | 2026 | 2248 |
| Number of Single+First+Last Authored Papers | 120 | 120 |
| Total Cites to Single+First+Last Authored Papers | 3393 | 4030 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7567 | 8194 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.42 |
| Self-Citation Percentage |
16.32%
|
|
Maruyama, Kazuo
Teikyo University,
Japan
2021 Rank: 37823
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 336 out of 131063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 37823 | 36251 |
| Total Cites | 8714 | 10425 |
| H-index | 44 | 50 |
| Hm-index | 16 | 18 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 577 | 584 |
| Number of Single+First Authored Papers | 47 | 47 |
| Total Cites to Single+First Authored Papers | 1983 | 2203 |
| Number of Single+First+Last Authored Papers | 111 | 111 |
| Total Cites to Single+First+Last Authored Papers | 3059 | 3673 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6686 | 7190 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.45 |
| Self-Citation Percentage |
16.41%
|
|
Maruyama, Kazuo
Teikyo University,
Japan
2020 Rank: 37451
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 327 out of 94611 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 37451 | 35209 |
| Total Cites | 8084 | 9682 |
| H-index | 42 | 49 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 519 | 526 |
| Number of Single+First Authored Papers | 47 | 47 |
| Total Cites to Single+First Authored Papers | 1869 | 2090 |
| Number of Single+First+Last Authored Papers | 110 | 110 |
| Total Cites to Single+First+Last Authored Papers | 2835 | 3407 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6169 | 6644 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.46 |
| Self-Citation Percentage |
16.50%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.